Diabetis mellitus and homoeopathic repertory
Not Applicable
Completed
- Conditions
- Health Condition 1: E119- Type 2 diabetes mellitus without complications
- Registration Number
- CTRI/2020/04/024560
- Lead Sponsor
- Dr Vidya More
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
a. Patients of DM type II of middle age adult [age-30 â?? 55].
b. Both sexes will be selected.
c. Reporting cases of symptoms of Diabetes d. Diagnosis is mainly based on clinical presentation, case history of patient and BGL reports fasting and Postprandial.
Exclusion Criteria
a.Cases with gross pathology
b.Exclude patient under immune- suppressive therapy
c.Patients with complication of diabetes
d.Case of Type I diabetes.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To Study the use of â??Concise repertory of Homoeopathic Medicines by Dr. S. R. Phatakâ??Timepoint: 18 month forem initiation
- Secondary Outcome Measures
Name Time Method treatment of Type II Diabetes mellitus by homoeopathic medicine with help of Phatak RepertoryTimepoint: type ii dm with reducing in BSL with in 18 months
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Does the Concise Repertory of Homeopathic Medicine by Dr. S.R. Phatak influence molecular pathways in Type 2 diabetes mellitus?
How does homeopathic treatment in CTRI/2020/04/024560 compare to standard-of-care therapies for E119 Type 2 diabetes in terms of glycemic control and adverse events?
Are there specific biomarkers associated with response to homeopathic interventions in Type 2 diabetes mellitus as observed in Dr. Vidya More's study?
What are the potential adverse events reported in homeopathic treatment of Type 2 diabetes mellitus in observational studies like CTRI/2020/04/024560?
How do homeopathic approaches in CTRI/2020/04/024560 align with current pharmacological strategies for managing E119 Type 2 diabetes mellitus?